Bicycle Therapeutics Stock Price Prediction

BCYC Stock  USD 19.45  0.56  2.80%   
The RSI of Bicycle Therapeutics' share price is below 30 at the present time suggesting that the stock is becoming oversold or undervalued. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Bicycle Therapeutics, making its price go up or down.

Oversold Vs Overbought

27

 
Oversold
 
Overbought
The successful prediction of Bicycle Therapeutics' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Bicycle Therapeutics, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Bicycle Therapeutics' stock price prediction:
EPS Estimate Next Quarter
(0.92)
EPS Estimate Current Year
(3.06)
EPS Estimate Next Year
(3.61)
Wall Street Target Price
37.8182
EPS Estimate Current Quarter
(0.78)
Using Bicycle Therapeutics hype-based prediction, you can estimate the value of Bicycle Therapeutics from the perspective of Bicycle Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Bicycle Therapeutics using Bicycle Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Bicycle using crowd psychology based on the activity and movement of Bicycle Therapeutics' stock price.

Bicycle Therapeutics Implied Volatility

    
  2.16  
Bicycle Therapeutics' implied volatility exposes the market's sentiment of Bicycle Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Bicycle Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Bicycle Therapeutics stock will not fluctuate a lot when Bicycle Therapeutics' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Bicycle Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Bicycle because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Bicycle Therapeutics after-hype prediction price

    
  USD 19.44  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.

Prediction based on Rule 16 of the current Bicycle contract

Based on the Rule 16, the options market is currently suggesting that Bicycle Therapeutics will have an average daily up or down price movement of about 0.14% per day over the life of the 2024-12-20 option contract. With Bicycle Therapeutics trading at USD 19.45, that is roughly USD 0.0263 . If you think that the market is fully incorporating Bicycle Therapeutics' daily price movement you should consider acquiring Bicycle Therapeutics options at the current volatility level of 2.16%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  
Check out Bicycle Therapeutics Basic Forecasting Models to cross-verify your projections.
For information on how to trade Bicycle Stock refer to our How to Trade Bicycle Stock guide.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bicycle Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
17.5125.5430.02
Details
Naive
Forecast
LowNextHigh
15.6420.1224.59
Details
13 Analysts
Consensus
LowTargetHigh
44.6649.0854.48
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.86-0.76-0.71
Details

Bicycle Therapeutics After-Hype Price Prediction Density Analysis

As far as predicting the price of Bicycle Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Bicycle Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Bicycle Therapeutics, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Bicycle Therapeutics Estimiated After-Hype Price Volatility

In the context of predicting Bicycle Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Bicycle Therapeutics' historical news coverage. Bicycle Therapeutics' after-hype downside and upside margins for the prediction period are 14.96 and 23.92, respectively. We have considered Bicycle Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
19.45
19.44
After-hype Price
23.92
Upside
Bicycle Therapeutics is not too volatile at this time. Analysis and calculation of next after-hype price of Bicycle Therapeutics is based on 3 months time horizon.

Bicycle Therapeutics Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Bicycle Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Bicycle Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Bicycle Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.01 
4.44
  0.01 
 0.00  
10 Events / Month
15 Events / Month
In about 10 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
19.45
19.44
0.05 
740.00  
Notes

Bicycle Therapeutics Hype Timeline

Bicycle Therapeutics is currently traded for 19.45. The entity has historical hype elasticity of -0.01, and average elasticity to hype of competition of 0.0. Bicycle is anticipated to decline in value after the next headline, with the price expected to drop to 19.44. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.05%, whereas the daily expected return is currently at 0.01%. The volatility of related hype on Bicycle Therapeutics is about 5920.0%, with the expected price after the next announcement by competition of 19.45. About 92.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.66. Some equities with similar Price to Book (P/B) outperform the market in the long run. Bicycle Therapeutics recorded a loss per share of 3.28. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next anticipated press release will be in about 10 days.
Check out Bicycle Therapeutics Basic Forecasting Models to cross-verify your projections.
For information on how to trade Bicycle Stock refer to our How to Trade Bicycle Stock guide.

Bicycle Therapeutics Related Hype Analysis

Having access to credible news sources related to Bicycle Therapeutics' direct competition is more important than ever and may enhance your ability to predict Bicycle Therapeutics' future price movements. Getting to know how Bicycle Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Bicycle Therapeutics may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
IDYAIdeaya Biosciences(0.53)6 per month 0.00 (0.23) 4.15 (5.09) 15.21 
ANABAnaptysBio(0.16)9 per month 0.00 (0.15) 5.77 (7.56) 35.57 
MGTXMeiraGTx Holdings PLC 0.07 8 per month 2.71  0.16  6.75 (5.78) 21.07 
KROSKeros Therapeutics 1.44 9 per month 2.19  0.14  5.38 (4.31) 16.94 
FIXXHomology Medicines(0.01)2 per month 3.52  0.01  5.77 (5.61) 19.43 
TNYATenaya Therapeutics(0.06)5 per month 4.63  0.07  12.11 (6.88) 38.23 
IGMSIGM Biosciences(0.26)7 per month 6.10  0.03  11.62 (9.42) 41.11 
GLUEMonte Rosa Therapeutics(0.23)9 per month 3.75  0.09  8.10 (8.18) 102.66 
STOKStoke Therapeutics(0.45)5 per month 0.00 (0.11) 4.60 (6.99) 21.35 
MRUSMerus BV(0.74)8 per month 0.00 (0.1) 3.33 (3.83) 10.85 
INBXInhibrx 0.11 6 per month 2.71 (0.01) 5.54 (6.11) 16.80 
IMTXWimmatics biotechnologies GmbH(0.03)2 per month 0.00 (0.21) 16.67 (19.17) 66.99 
SEERSeer Inc 0.02 5 per month 1.73  0.18  6.32 (3.03) 15.38 
ORICOric Pharmaceuticals 0.03 10 per month 0.00 (0.04) 5.64 (5.60) 23.18 
ANEBAnebulo Pharmaceuticals(0.02)5 per month 7.16 (0.01) 8.61 (11.48) 76.00 
CGEMCullinan Oncology LLC(0.23)9 per month 0.00 (0.19) 5.88 (7.24) 17.85 
CCCCC4 Therapeutics 0.02 9 per month 0.00 (0.13) 8.59 (7.98) 23.66 
ADAGAdagene(0.01)6 per month 0.00 (0.03) 8.13 (9.52) 37.93 
ACRVAcrivon Therapeutics, Common(0.60)5 per month 0.00 (0.1) 6.90 (7.65) 22.84 
MLYSMineralys Therapeutics, Common 0.14 9 per month 3.50  0  6.27 (5.79) 20.98 

Bicycle Therapeutics Additional Predictive Modules

Most predictive techniques to examine Bicycle price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Bicycle using various technical indicators. When you analyze Bicycle charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Bicycle Therapeutics Predictive Indicators

The successful prediction of Bicycle Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Bicycle Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Bicycle Therapeutics based on analysis of Bicycle Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Bicycle Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Bicycle Therapeutics's related companies.
 2023 2024 (projected)
Payables Turnover0.50.47
Days Of Inventory On Hand1.14E-41.08E-4

Story Coverage note for Bicycle Therapeutics

The number of cover stories for Bicycle Therapeutics depends on current market conditions and Bicycle Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Bicycle Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Bicycle Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Bicycle Therapeutics Short Properties

Bicycle Therapeutics' future price predictability will typically decrease when Bicycle Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Bicycle Therapeutics often depends not only on the future outlook of the potential Bicycle Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bicycle Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding35.6 M
Cash And Short Term Investments526.4 M

Complementary Tools for Bicycle Stock analysis

When running Bicycle Therapeutics' price analysis, check to measure Bicycle Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bicycle Therapeutics is operating at the current time. Most of Bicycle Therapeutics' value examination focuses on studying past and present price action to predict the probability of Bicycle Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bicycle Therapeutics' price. Additionally, you may evaluate how the addition of Bicycle Therapeutics to your portfolios can decrease your overall portfolio volatility.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities